BioPharma Dive – AI / Data
Aspen’s fresh Parkinson’s data; Aldeyra tanks following FDA rejection
Helixgate AI & Biotech Collaboration Series + Helixgate Industry Nights brings together leaders and professionals from biotechnology, pharma, artificial intelligence, science, technology, medicine and healthcare for an evening of industry insights, networking and collaboration.
Date: October 22, 2026
Location: Del Mar Social, San Diego, California
Reserve your spot and purchase tickets on Eventbrite:
https://www.eventbrite.com/e/helixgate-ai-biotech-collaboration-series-helixgate-industry-nights-tickets-1998469781915?aff=oddtdtcreator
The treatment, tozorakimab, succeeded where other similar therapies failed and could help a broader group of COPD patients than Dupixent.
Worth up to $2 billion, the deal is centered around a drug that could lead to faster and more complete control of allergic conditions than Novartis and Roche’s popular medicine.
FDA clears first generic radioligand drug; Sionna turns to layoffs
WCLC ‘26: A new ‘ADC era,’ China questions and AstraZeneca’s spotlight
Ensuring safety and accountability in China’s biomedical translation system
FDA launches pilot program to speed up early US drug research
FDA launches pilot program to speed up sluggish phase 1 trials
Connect’s Dupixent rival flunks phase 2 asthma trial, but biotech sees reasons for hope
-
Fierce Biotech6 months ago
Scientists turn pig semen extract into eye drops that kill cancer in mice
-
Endpoints News6 months ago
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
-
Uncategorized6 months agoNovartis buys Synnovation’s PI3Kα inhibitors for $3 billion
-
Nature Biotechnology6 months ago
Sustained nitric oxide production by engineered E. coli remodels the tumor microenvironment and potentiates immunotherapy
-
Uncategorized4 months agoOptical Pooled CRISPR Screen Reveals Regulators of NF-κB Dynamics in Human Cells
-
Uncategorized4 months ago
Relay’s PI3Kα inhibitor clears efficacy bar in Phase 2 vascular anomalies study
-
STAT News – Biotech6 months agoSTAT+: In private meetings, White House works to win pharma companies’ support for drug pricing bill
-
Nature Biotechnology6 months ago
Mapping cis-regulatory mutations at scale in sorghum enables modulation of gene expression
Scan to Read